The Annexin A5-1C/T polymorphism in ischemic stroke: A case-control study [3]

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 1, 2005, Pages 173-175

  Van Goor, M L P J ^a   Van Heerde, W L ^b   Schoormans, S ^b   Dippel, D W J ^a   Leebeek, F W G ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; LIPOCORTIN 5;

ADULT; AGED; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE SEQUENCE; GENETIC POLYMORPHISM; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; ALLELE; GENETICS; GENOTYPE; ISCHEMIA; MIDDLE AGED; MUTATION; RISK;

ADULT; AGED; ALLELES; ANNEXIN A5; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; FEMALE; GENOTYPE; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; MUTATION; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; RISK;

EID: 20444451280     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.01096.x     Document Type: Letter

References (12)

1. Reutelingsperger CPM, Hornstra G, Hemker HC. Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. Eur J Biochem 1985; 151: 625-9.
2. Van Heerde WL, de Groot PG, Reutelingsperger C. The complexity of the phospholipid binding protein annexin V. Thromb Haemost 1995; 73: 172-9.
3. Thiagarajan P, Benedict CR. Inhibition of arterial thrombosis by recombinant annexin V in a rabbit carotid artery injury model. Circulation 1997; 96: 2339-47.
4. Cookson BT, Engelhardt S, Smith C, Bamford HA, Prochazka M, Tait JF. Organization of the human annexin V (ANX5) gene. Genomics 1994; 20: 463-7.
5. Van Heerde W, Jumilly A-L, Lux P, Meyer D, Hamulyak K, Lavergne J-M, Reutelingsperger CPM. Mutations in the Annexin V gene, a new risk factor for venous thrombosis? Thromb Haemost 1999; Suppl. 1: 537.
6. Gonzalez-Conejero R, Corral J, Rolda'n V, Martinez C, Marin F, Rivera J, Iniesta JA, Lozano M, Marco P, Vicente V. A common polymorphism in the annexin V Kozak sequence (-1C/T) increases efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients. Blood 2002; 100: 2081-6.
7. Kenis H, Doggen CJ, Vos HL, Reutelingsperger C, Van Heerde W. The C-IT mutation in the annexin A5 Kozak sequence slightly increases the risk of myocardial infarction in men. J Thromb Haemost 2003; 1: 2688-9.
8. Van Heerde WL, Kenis H, Schoormans S, Lap P, Reutelingsperger CPM. The -1C/T mutation in the annexin A5 gene does not affect plasma levels of annexin A5. Blood 2003; 101: 4223-4.
9. Adams Jr HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE, and the TOAST investigators. Classification of subtype of acute ischemic stroke. Stroke 1993; 24: 35-41.
10. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463-7.
11. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J 1965; 14: 61-5.
12. Spreafico M, Peyvandi F, Tagliabue L, Merlini PM, Mannucci PM. Lack of association between the annexin V gene -1C/T polymorphism and acute myocardial infarction in 150 young Italian women. J Thromb Haemost 2003; Suppl. 1: P1005.